(April 4, 2016, 2:06 PM EDT) -- SAN FRANCISCO — A plaintiff in a Cymbalta withdrawal cases and drug manufacturer Eli Lilly and Co. on March 31 told the Ninth Circuit U.S. Court of Appeals that they have resolved the plaintiff’s appeal of a defense verdict (Claudia Herrera v. Eli Lilly and Company, No. 15-56362, 9th Cir.)....